Trial Details
COMPLETEDBasic Information
| Clinical ID | c2619 |
|---|---|
| Identifier | NCT03219528 |
| Trial Title | A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: Rifaximin 550 MG|OTHER: Low FODMAP Diet |
Participant Information
| Sponsor | University of Michigan |
|---|---|
| City | Ann Arbor |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2018-02-13 |
|---|---|
| Primary Completion Date | 2024-02-28 |
| Completion Date | 2024-02-28 |